Disc Medicine stock is hit by an FDA CRL for bitopertin. Learn key trial risks, cash runway, and why APOLLO Phase 3 results ...

During a live event, Hagen Kennecke, MD, discusses how RADIANT-4 and NETTER trials have reshaped NET care with everolimus and PRRT.

This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...

Onyx is a liquid embolic agent that is injected into an artery to occlude blood flow. In subdural hematoma, it is used to block the MMA, stopping the chronic oozing of blood into the subdural space.

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

While WeirdCo and CDPR's Cyberpunk 2077 TCG perfectly captures the RPG's 'rags to riches' grind, its mechanics are a little ...

The Trump administration has sought to pressure Senator Chuck Schumer, Democrat of New York and the minority leader, to help name New York’s Penn Station and Washington Dulles International Airport ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after prior targeted treatment.

As darkness retreats and flotation tanks gain popularity, a UCSD professor examines how “sensory deprivation” experiments ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

I got five hours of sleep last night.